Form 4 for CADL Candel Therapeutics, Inc.
Accepted 2024-10-28 00:00:00 ET · period of report 2024-10-24 · accession 0001873919-24-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-10-28 | 2024-10-24+ | CADL | Aguilar Laura K. | 10% | D - Sale to Iss | $5.57 | -30.9K | 900.2K | -3% | -$172.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | CADL | 2024-10-24 | D | D | 16,427 | $5.53 | 903,034 | D | — | — | |
| 2 | Common | CADL | 2024-10-28 | D | D | 11,711 | $5.58 | 888,532 | D | — | — | |
| 3 | Common | CADL | 2024-10-24 | D | D | 1,194 | $5.72 | 901,840 | D | — | — | |
| 4 | Common | CADL | 2024-10-25 | D | D | 1,597 | $5.80 | 900,243 | D | — | — |